Pharmacogenetics and pharmacogenomics of anticancer agents.

CA: a Cancer Journal for Clinicians
R Stephanie Huang, Mark J Ratain

Abstract

Large interindividual variation is observed in both the response and toxicity associated with anticancer therapy. The etiology of this variation is multifactorial, but is due in part to host genetic variations. Pharmacogenetic and pharmacogenomic studies have successfully identified genetic variants that contribute to this variation in susceptibility to chemotherapy. This review provides an overview of the progress made in the field of pharmacogenetics and pharmacogenomics using a five-stage architecture, which includes 1) determining the role of genetics in drug response; 2) screening and identifying genetic markers; 3) validating genetic markers; 4) clinical utility assessment; and 5) pharmacoeconomic impact. Examples are provided to illustrate the identification, validation, utility, and challenges of these pharmacogenetic and pharmacogenomic markers, with the focus on the current application of this knowledge in cancer therapy. With the advance of technology, it becomes feasible to evaluate the human genome in a relatively inexpensive and efficient manner; however, extensive pharmacogenetic research and education are urgently needed to improve the translation of pharmacogenetic concepts from bench to bedside.

Citations

Dec 22, 2009·Carcinogenesis·Margaret R Spitz, Melissa L Bondy
Sep 12, 2009·Pharmacogenetics and Genomics·Eric R GamazonNancy J Cox
Aug 24, 2010·Pharmacogenetics and Genomics·Soonmo Peter KangMark J Ratain
Jul 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter H O'Donnell, M Eileen Dolan
Jul 22, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiang-Lin TanLiewei Wang
May 26, 2011·Genome Biology·Eric R GamazonNancy J Cox
Oct 19, 2013·Genome Medicine·R Stephanie Huang, Eric R Gamazon
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Sarah RofaielShaker A Mousa
Feb 16, 2011·Biomarkers in Medicine·George C Zografos, Dimitrios H Roukos
Feb 12, 2013·Pharmacogenomics·Liming WengR Stephanie Huang
Apr 21, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Raffaele Di FranciaLuigi Formisano
Jan 15, 2014·Leukemia & Lymphoma·Fausto R LoberizaPhilip J Bierman
Jul 3, 2015·Oncology Reports·Diana Cervantes-Madrid, Alfonso Dueñas-González
Sep 25, 2012·Metabolism: Clinical and Experimental·Madhu Kalia
Jul 20, 2010·Cancer Epidemiology·Luis Alberto Henríquez-HernándezLeandro Fernández-Pérez
Nov 17, 2009·Critical Reviews in Oncology/hematology·Giannis MountziosChristos A Papadimitriou
Jun 23, 2009·The Journal of Urology·Hiroshi HirataRajvir Dahiya
Apr 5, 2012·Journal of the Science of Food and Agriculture·Salvatore Chirumbolo
Nov 29, 2012·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Xiuqin NiR Stephanie Huang
Oct 17, 2012·International Journal of Dermatology·Zendee ElabaMichael J Murphy
Nov 29, 2013·International Journal of Cancer. Journal International Du Cancer·Jie LuoGarth L Warnock
Dec 7, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Li LiuDongxin Lin
Jul 8, 2015·The Pharmacogenomics Journal·A H KhanD J Smith
Dec 27, 2011·Cancer Biology & Therapy·Shannon N Westin, Russell R Broaddus
Sep 21, 2013·Experimental Cell Research·Argha NandyAshis Mukhopadhyay
Jan 13, 2015·Cellular Oncology (Dordrecht)·Chiara PesentiMonica Miozzo
Mar 12, 2015·Japanese Journal of Clinical Oncology·Jinichi MoriMasahiro Kami
Jul 28, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Wen LiZhe-Sheng Chen
May 16, 2012·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Michael J Duffy
Sep 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kenneth Offit, Mark E Robson
Nov 17, 2010·Current Oncology Reports·Terri S Armstrong, Mark R Gilbert
May 26, 2009·Cancer Chemotherapy and Pharmacology·Ken-ichi FujitaYasutsuna Sasaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.